1-(2,3-Dichlorophenyl)piperazine Hydrochloride CAS 119532-26-2 Aripiprazole Intermediate Purity>99.0% (HPLC)

Tsanangudzo Pfupi

Zita: 1-(2,3-Dichlorophenyl)piperazine Hydrochloride

Anoreva zvakafanana: 2,3-DCPP HCl

CAS: 119532-26-2

Kuchena:> 99.0% (HPLC)

Chitarisiko: White kana Off-White Powder

Pakati peAripiprazole (CAS: 129722-12-9)

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Tsanangudzo:

Chemical Properties:

Chemical Name 1-(2,3-Dichlorophenyl)piperazine Hydrochloride
Mashoko anoreva zvakafanana 2,3-DCPP HCl;1-(2,3-Dichlorophenyl)piperazine HCl;Aripiprazole EP Kusachena B;Aripiprazole Related Compound C
Nhamba yeCAS 119532-26-2
Nhamba yeCAT RF-PI2268
Stock Status MuStock, Kukwanisa Kugadzira 30 MT/Mwedzi
Molecular Formula C10H12Cl2N2·HCl
Molecular Weight 267.58
Melting Point 245.0~247.0℃
Kuchengeta & Sensitivity Hygroscopic.Ambient tembiricha
Solubility mumvura Soluble mumvura
Brand Ruifu Chemical

Zvinotsanangurwa:

Item Zvinotsanangurwa
Chitarisiko White kana Off-White Powder
Kuchena / Analysis Method >99.0% (HPLC)
Kurasika paKuomesa <0.50%
Residue paIgnition <0.10%
Kusachena Kumwechete <0.50%
Zvose Zvisina Kuchena <1.00%
Heavy Metals (as Pb) ≤20ppm
Infrared Spectrum Inopindirana neChimiro
Test Standard Enterprise Standard
Usage Pakati peAripiprazole (CAS: 129722-12-9)

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Hygroscopic.Chengetedza kure nemvura / unyoro uye oxidizing agents.Chengetedza mudziyo wakavharwa zvakasimba woiisa munzvimbo inotonhorera, yakaoma uye ine mhepo yakanaka.Chengetedza pasi pegesi inert

Zvakanakira:

1

FAQ:

Application:

1-(2,3-Dichlorophenyl)piperazine Hydrochloride (CAS: 119532-26-2) inokosha yepakati yeAripiprazole (CAS: 129722-12-9).Aripiprazole rudzi rutsva rwezvakanyanya lipid soluble quinoline derivatives, iyo pharmacological mhedzisiro hunhu ndeyekuti haisi chete postsynaptic dopamine D 2 receptor antagonist, asiwo presynaptic dopamine D 2 receptor agonist, inogona zvakare kufadza D 1, D 3, D 4 receptors;ine huviri mhedzisiro yekusarudzika activation kana receptor antagonistic pa5-HT 1A receptor;ine chiito chinopesana zvachose pane 5-HT 2A receptor.Ichi chimiro chakasiyana nechizvarwa chekutanga, uye atypical antipsychotics inova yechizvarwa chechipiri antipsychotic mishonga, uye nekudaro inonzi dopamine system stabilizer kana yechitatu chizvarwa antipsychotic.Sezvo ichitengeswa mumusika, inonyanya kushandiswa mukiriniki schizophrenia, kurapwa kweanokanganisa kusagadzikana uye zvimwe zvirwere zvepfungwa.Zvinoenderana nemabhuku, aripiprazole ine zvakakosha mhedzisiro pane schizophrenia yakanaka uye yakaipa zviratidzo uye kusagadzikana, kushushikana, kugona kwekuziva, nepo kuchengetedzwa kwepamusoro.Zvakataurwawo kuti mushonga unogona kurapa zvimwe zvirwere zvepfungwa, zvakadai sezvinyamusi manic episodes, senile dementia yakabatana nekukanganisika kwepfungwa, kusagadzikana kwekuzvidya mwoyo, maitiro evana, kuora mwoyo.Mazuva ano, Bristol-Myers Squibb neOtsuka Pharmaceutical Company yakazivisa kuti European Union yakabvumidza Abilify (aripiprazole) mukurapa schizophrenia rondedzero application.

Nyora meseji yako pano uye titumire kwatiri